4.8 Article

Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes

Journal

SCIENCE
Volume 365, Issue 6450, Pages 250-+

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aav9518

Keywords

-

Funding

  1. European Research Council
  2. Wellcome Trust [099222/Z/12/Z]
  3. National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre
  4. UCL Sea and Currents grant
  5. Leonard Wolfson Experimental Neurology Centre PhD studentship
  6. BBSRC LIDo PhD studentship
  7. Chulabhorn Royal Academy PhD studentship
  8. EMBO fellowship
  9. Lundbeck Foundation fellowship
  10. Deutsche Forschungsgemeinschaft Sino-German [Kl 503/14-1]
  11. DFG [SFB894]
  12. Wellcome Trust
  13. Wellcome Trust [099222/Z/12/Z] Funding Source: researchfish

Ask authors/readers for more resources

Cerebral blood flow is reduced early in the onset of Alzheimer's disease (AD). Because most of the vascular resistance within the brain is in capillaries, this could reflect dysfunction of contractile pericytes on capillary walls. We used live and rapidly fixed biopsied human tissue to establish disease relevance, and rodent experiments to define mechanism. We found that in humans with cognitive decline, amyloid beta (A beta) constricts brain capillaries at pericyte locations. This was caused by A beta generating reactive oxygen species, which evoked the release of endothelin-1 (ET) that activated pericyte ETA receptors. Capillary, but not arteriole, constriction also occurred in vivo in a mouse model of AD. Thus, inhibiting the capillary constriction caused by A beta could potentially reduce energy lack and neurodegeneration in AD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available